Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
128,032,712
-
Share change
-
-1,843,461
-
Total reported value
-
$31,346,245,073
-
Put/Call ratio
-
100%
-
Price per share
-
$244.86
-
Number of holders
-
1,039
-
Value change
-
-$509,592,628
-
Number of buys
-
375
-
Number of sells
-
561
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q4 2020
As of 31 Dec 2020,
BIOGEN INC. - COM (BIIB) was held by
1,039 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
128,032,712 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, Clearbridge Investments, LLC, RENAISSANCE TECHNOLOGIES LLC, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, and NORTHERN TRUST CORP.
This page lists
1,045
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.